BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of SEK 17.81 billion. The enterprise value is 17.07 billion.

Market Cap	17.81B
Enterprise Value	17.07B

Important Dates

The last earnings date was Wednesday, May 21, 2025.

Earnings Date	May 21, 2025
Ex-Dividend Date	n/a

Share Statistics

BioArctic AB has 88.53 million shares outstanding. The number of shares has increased by 0.36% in one year.

Current Share Class	74.13M
Shares Outstanding	88.53M
Shares Change (YoY)	+0.36%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	33.46%
Owned by Institutions (%)	49.16%
Float	53.14M

Valuation Ratios

The trailing PE ratio is 19.77 and the forward PE ratio is 20.68.

PE Ratio	19.77
Forward PE	20.68
PS Ratio	11.74
PB Ratio	9.21
P/TBV Ratio	9.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.92, with an EV/FCF ratio of -78.77.

EV / Earnings	18.93
EV / Sales	11.25
EV / EBITDA	17.92
EV / EBIT	18.56
EV / FCF	-78.77

Financial Position

The company has a current ratio of 13.39, with a Debt / Equity ratio of 0.03.

Current Ratio	13.39
Quick Ratio	5.21
Debt / Equity	0.03
Debt / EBITDA	0.05
Debt / FCF	-0.24
Interest Coverage	65.14

Financial Efficiency

Return on equity (ROE) is 61.64% and return on invested capital (ROIC) is 38.56%.

Return on Equity (ROE)	61.64%
Return on Assets (ROA)	35.28%
Return on Invested Capital (ROIC)	38.56%
Return on Capital Employed (ROCE)	46.65%
Revenue Per Employee	13.08M
Profits Per Employee	7.78M
Employee Count	107
Asset Turnover	0.93
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.20% in the last 52 weeks. The beta is -0.74, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.74
52-Week Price Change	-17.20%
50-Day Moving Average	181.28
200-Day Moving Average	185.46
Relative Strength Index (RSI)	61.52
Average Volume (20 Days)	428,321

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of SEK 1.52 billion and earned 901.96 million in profits. Earnings per share was 10.18.

Revenue	1.52B
Gross Profit	1.48B
Operating Income	919.83M
Pretax Income	933.95M
Net Income	901.96M
EBITDA	939.30M
EBIT	919.83M
Earnings Per Share (EPS)	10.18

Full Income Statement

Balance Sheet

The company has 788.57 million in cash and 50.99 million in debt, giving a net cash position of 737.57 million or 8.33 per share.

Cash & Cash Equivalents	788.57M
Total Debt	50.99M
Net Cash	737.57M
Net Cash Per Share	8.33
Equity (Book Value)	1.93B
Book Value Per Share	21.85
Working Capital	1.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -190.14 million and capital expenditures -26.64 million, giving a free cash flow of -216.77 million.

Operating Cash Flow	-190.14M
Capital Expenditures	-26.64M
Free Cash Flow	-216.77M
FCF Per Share	-2.45

Full Cash Flow Statement

Margins

Gross margin is 97.61%, with operating and profit margins of 60.62% and 59.44%.

Gross Margin	97.61%
Operating Margin	60.62%
Pretax Margin	61.55%
Profit Margin	59.44%
EBITDA Margin	61.91%
EBIT Margin	60.62%
FCF Margin	n/a

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.36%
Shareholder Yield	n/a
Earnings Yield	5.06%
FCF Yield	-1.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a